SCHEMBL14506990

SCHEMBL14506990

c1ccc(N(c2ccc(N(c3ccccc3)c3ccc4c(c3)CC4)cc2)c2ccc3c(c2)CC3)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ CRHBP P24387 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ CRHR2 Q13324 1/20 0.39
▸ TLR9 Q9NR96 1/20 0.39
▸ HTR2C P28335 2/20 0.37
▸ HTR2B P41595 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11898477 1.00 ALDH1A1 (0.46) ALDH1A1L3MBTL1MAPTTDP1KDM4E
SCHEMBL17841771 1.00 ALDH1A1 (0.46) ALDH1A1L3MBTL1MAPTTDP1KDM4E
SCHEMBL14786665 0.92 TSHR (0.46) ALDH1A1L3MBTL1MAPTTDP1KDM4E
SCHEMBL8852754 0.92 ALDH1A1 (0.43) ALDH1A1L3MBTL1MAPTTDP1KDM4E
SCHEMBL17430706 0.91 ALDH1A1 (0.39) ALDH1A1L3MBTL1MAPTTDP1KDM4E
SCHEMBL17961923 0.91 ALDH1A1 (0.39) ALDH1A1L3MBTL1MAPTTDP1KDM4E
SCHEMBL17987014 0.88 TP53 (0.42) ALDH1A1L3MBTL1MAPTTDP1KDM4E
SCHEMBL22002995 0.88 ALDH1A1 (0.37) ALDH1A1L3MBTL1MAPTTDP1KDM4E
SCHEMBL13670139 0.87 TSHR (0.41) ALDH1A1L3MBTL1MAPTTDP1KDM4E
SCHEMBL13152150 0.87 ALDH1A1 (0.39) ALDH1A1L3MBTL1MAPTTDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9399702-B2 Crosslinkable arylamine compounds and conjugated oligomers or polymers based thereon SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-07-26 — — US disclosed
US-9399702-B2 Crosslinkable arylamine compounds and conjugated oligomers or polymers based thereon SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-07-26 — — US disclosed
US-20070096082-A1 Crosslinkable arylamine compounds and conjugated oligomers or polymers based thereon DOW GLOBAL TECHNOLOGIES INC. 2007-05-03 — — US disclosed
US-20070096082-A1 Crosslinkable arylamine compounds and conjugated oligomers or polymers based thereon DOW GLOBAL TECHNOLOGIES INC. 2007-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070096082-A1 Crosslinkable arylamine compounds and conjugated oligomers or polymers based thereon PNMT, AHR, TYR ALDH1A1 711/4885L3MBTL1 3281/4885MAPT 121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback